NEW YORK (Reuters Health) – Rituximab monotherapy is “a very good option” for severe cryoglobulinemic vasculitis (CV), according to the authors of an Italian study published online December…
NEW YORK (Reuters Health) – Moxifloxacin is as effective as amoxicillin/clavulanic acid in the treatment of exacerbations of chronic obstructive pulmonary disease (COPD) in the outpatient setting, according…
NEW YORK (Reuters Health) – At 5 years, bipolar radiofrequency (RF) endometrial ablation is more effective than hydrothermablation for controlling menorrhagia, according to a Dutch study reported in…
NEW YORK (Reuters Health) – To combat psoriasis, a combination of topical therapies seems to work better than topical monotherapy, according to results of a systematic review and…
NEW YORK (Reuters Health) – Antibiotic prophylaxis with cefazolin during elective cesarean delivery, administered either before skin incision or after umbilical cord clamping, reduced postoperative maternal infections by…
NEW YORK (Reuters Health) – Tonsillectomy is an effective treatment for children with dysphagia related to enlarged tonsils, according to results of a prospective cohort study. Removing the…
NEW YORK (Reuters Health) Results of a retrospective study confirm that the Rule of 7’s prediction tool accurately identifies children who are unlikely to have Lyme meningitis, investigators…
NEW YORK (Reuters Health) – Vaginal progesterone given to pregnant women with mid-trimester sonographic evidence of short cervix reduces the risk of preterm birth and neonatal complications and…
NEW YORK (Reuters Health) Pooled data from four relatively small but high-quality prospective randomized controlled studies suggest an advantage to intracoronary (IC) over intravenous (IV) administration of abciximab…
NEW YORK (Reuters Health) Treatment for up to 24 months with fesoterodine (Toviaz; Pfizer Inc) may yield sustained improvement in bladder problems and health-related quality of life in…
